Model Predicts Risk for Patients on Waitlist for Cardiac Surgery
Clinical risk model predicts risk for composite outcome of death and unplanned cardiac hospitalization for patients on cardiac surgery waitlist.
Transplantation
Monoclonal Antibodies for COVID-19 Effective for Transplant Patients
Favorable outcomes, minimal adverse effects seen in solid organ transplant recipients who received monoclonal antibody therapy for COVID-19.
Heart Transplant Outcomes Comparable in Advanced Age
Survival up to five years after a heart transplant is similar for patients aged 70 years and older and those younger than 70 years.
Assessment of Cardiac Risk Stratification in Liver Transplantation
Adult patients anticipating liver transplantation could benefit from the selective use of three-tiered cardiac risk stratification protocol.
Mortality Risk Higher for Young Black Heart Recipients
Young Black heart recipients have an increased risk for mortality in the first year after transplant.
Blood Biomarker May Detect Acute Heart Transplant Rejection
Blood test measuring percent donor-derived cell-free DNA could eliminate much of the need for endomyocardial biopsy.
Severely Obese Heart Donors Not Tied to Adverse Transplant Outcomes
Severe obesity in organ donors is not associated with adverse heart transplant outcomes.
Heart Transplant Volumes Decreased in COVID-19 Era
In the COVID-19 era, there has been a decrease in heart transplant (HT) volumes.
Thoracic Organ Transplantation Options for Eisenmenger Syndrome Treatment
Thoracic organ transplantation remains a viable treatment option in patients with Eisenmenger Syndrome, although these patients are considered higher risk than other potential transplant recipients.
Factors Predicting Renal Failure After Total Artificial Heart Implantation
Lower baseline eGFR and a history of coronary artery disease may predict the risk for hemodialysis after total artificial heart implantation.
- Loading...
Loading...
Next post in Heart Failure
Loading... 
Loading...